3-[5-[(dimethylamino)methyl]-2-pyridinyl]-N-[(3S)-1,1-dioxo-2,3-dihydrothiophen-3-yl]benzamide
C19H21N3O3S — CID 125158827
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[5-[(dimethylamino)methyl]-2-pyridinyl]-N-[(3S)-1,1-dioxo-2,3-dihydrothiophen-3-yl]benzamide
3-[5-[(dimethylamino)methyl]-2-pyridinyl]-N-[(3S)-1,1-dioxo-2,3-dihydrothiophen-3-yl]benzamide (PubChem CID 125158827) has the molecular formula C19H21N3O3S and a molecular weight of 371.46 g/mol. Its IUPAC name is 3-[5-[(dimethylamino)methyl]-2-pyridinyl]-N-[(3S)-1,1-dioxo-2,3-dihydrothiophen-3-yl]benzamide.
Molecular Properties
| Compound Name | 3-[5-[(dimethylamino)methyl]-2-pyridinyl]-N-[(3S)-1,1-dioxo-2,3-dihydrothiophen-3-yl]benzamide |
|---|---|
| PubChem CID | 125158827 |
| Molecular Formula | C19H21N3O3S |
| Molecular Weight | 371.46 g/mol |
| Exact Mass | 371.13 |
| IUPAC Name | 3-[5-[(dimethylamino)methyl]-2-pyridinyl]-N-[(3S)-1,1-dioxo-2,3-dihydrothiophen-3-yl]benzamide |
| SMILES | CN(C)Cc1ccc(-c2cccc(C(=O)N[C@H]3C=CS(=O)(=O)C3)c2)nc1 |
| InChI | InChI=1S/C19H21N3O3S/c1-22(2)12-14-6-7-18(20-11-14)15-4-3-5-16(10-15)19(23)21-17-8-9-26(24,25)13-17/h3-11,17H,12-13H2,1-2H3,(H,21,23)/t17-/m0/s1 |
| InChIKey | XDQSOUKGMIHSPM-KRWDZBQOSA-N |
| XLogP | 1.85 |
| TPSA | 79.37 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 371.46 |
| LogP ≤ 5 | 1.85 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 125158827 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.